David A. Morrow, MD, MPH is an Associate Professor of Medicine at Harvard Medical School, and the Director of the Samuel A. Levine Cardiac Intensive Care Unit in the Division of Cardiovascular Medicine at Brigham and Women's Hospital. Dr. Morrow earned his medical degree from Harvard Medical School and a masters in public health with a concentration in clinical study design and interpretation from the Harvard School of Public Health. He completed his medical residency in internal medicine and fellowship in cardiovascular medicine at Brigham and Women's Hospital.
Dr. Morrow is a Senior Investigator in the Thrombolysis in Myocardial Infarction Study Group at Brigham and Women's Hospital with a research focus in the management of unstable and stable coronary artery disease, and he directs the TIMI Biomarker Program. He has been the Principal Investigator for 5 multicenter cardiovascular trials, including the recently completed multinational TRA 2°P-TIMI 50 trial of a novel oral antiplatelet agent for secondary prevention among 25,000 subjects with atherosclerosis.
He is an internationally recognized expert in risk stratification in patients with ischemic heart disease. He has served on the National Academy of Clinical Biochemistry (NACB) Laboratory Medicine Practice Guidelines Committee on Biochemical Cardiac Markers, for which he led the clinical section on acute coronary syndromes, and on the Program Committee for the American Heart Association Council on Clinical Cardiology. He is a member of the Global Task Force for a Universal Definition of Myocardial Infarction and the ACC/AHA Guidelines Committee for ST-elevation Myocardial Infarction. He sits on the editorial boards of the American Heart Journal, Circulation, Clinical Chemistry, and the Journal of the American College of Cardiology. He is a special section Co-editor for Continuing Medical Education at Circulation. He has been the recipient of the Lerner Young Investigator Award, the William W. Parmley Young Author Achievement Award, and the Eugene Braunwald Teaching Award. Dr. Morrow has more than 150 original scientific reports, reviews, editorials, book chapters, and electronic publications in his areas of expertise, and is the editor of Cardiovascular Biomarkers, a text on application of biomarkers in cardiovascular disease.